Source: CURATED

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.600 Therapeutic CTD_human Trastuzumab increases the clinical benefit of first-line chemotherapy in metastatic breast cancer that overexpresses HER2. 11248153

2001
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.600 Biomarker CTD_human This study suggests that in node-positive breast cancer patients randomly treated with CMF or an epirubicin-based regimen, the predictive value of HER-2 may vary according to the Abs used in the immunohistochemistry assay. 11583189

2001
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.600 Biomarker CTD_human Trastuzumab increases the clinical benefit of first-line chemotherapy in metastatic breast cancer that overexpresses HER2. 11248153

2001
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.600 Therapeutic CTD_human HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes. 10897039

2000
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.600 Biomarker CTD_human HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes. 10897039

2000
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.600 GenomicAlterations CGI

Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma 		0.600 CausalMutation CGI